Cargando…
Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features
BACKGROUND: Breast cancer is a complex heterogeneous disease and is one of the leading causes of death among women. In addressing the need for treatments of this life-threatening illness, we studied 3,4-dihydropyrimidin-2(1H)-one (or thione) derivatives (DHPMs), a class of inhibitor molecules of the...
Autores principales: | Guido, Bruna C, Ramos, Luciana M, Nolasco, Diego O, Nobrega, Catharine C, Andrade, Bárbara YG, Pic-Taylor, Aline, Neto, Brenno AD, Corrêa, José R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411898/ https://www.ncbi.nlm.nih.gov/pubmed/25885813 http://dx.doi.org/10.1186/s12885-015-1274-1 |
Ejemplares similares
-
Non‐canonical functions of the mitotic kinesin Eg5
por: Liu, Min, et al.
Publicado: (2018) -
Kinesin-14 HSET may not oppose kinesin-5 Eg5 activity in RPE-1 cells
por: Carlier-Grynkorn, Frederique, et al.
Publicado: (2022) -
Kinesin molecular motor Eg5 functions during polypeptide synthesis
por: Bartoli, Kristen M., et al.
Publicado: (2011) -
Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5
por: Exertier, Prisca, et al.
Publicado: (2013) -
The kinesin Eg5 drives poleward microtubule flux in Xenopus laevis egg extract spindles
por: Miyamoto, David T., et al.
Publicado: (2004)